These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1228 related articles for article (PubMed ID: 6616412)
1. Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion. Martijn H; Oldhoff J; Oosterhuis JW; Koops HS Cancer; 1983 Oct; 52(8):1526-34. PubMed ID: 6616412 [TBL] [Abstract][Full Text] [Related]
2. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin]. Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344 [TBL] [Abstract][Full Text] [Related]
3. The surgical treatment of a melanoma patient with macroscopic metastasis in peri and retrocaval lymph nodes and with a positive sentinel lymph node in the groin. Giudice G; Robusto F; Nacchiero E Ann Ital Chir; 2016 Feb; 87(ePub):. PubMed ID: 26903177 [TBL] [Abstract][Full Text] [Related]
4. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis. Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717 [TBL] [Abstract][Full Text] [Related]
6. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I]. Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460 [TBL] [Abstract][Full Text] [Related]
7. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031 [TBL] [Abstract][Full Text] [Related]
8. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin--an analysis of survival and local recurrence. Kretschmer L; Neumann C; Preusser KP; Marsch WC Acta Oncol; 2001; 40(1):72-8. PubMed ID: 11321665 [TBL] [Abstract][Full Text] [Related]
9. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Spillane AJ; Haydu L; McMillan W; Stretch JR; Thompson JF Ann Surg Oncol; 2011 Sep; 18(9):2521-8. PubMed ID: 21556951 [TBL] [Abstract][Full Text] [Related]
10. [Sentinel node biopsy in cutaneous malignant melanoma of the lower extremities]. Kjaer BK; Knudsen MA; Dahlstrøm KK Ugeskr Laeger; 1999 Apr; 161(16):2358-61. PubMed ID: 10235040 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
12. [Preventive lymph node excision in the treatment concept of melanoma of the extremities]. Binder J; Henneking K Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334 [TBL] [Abstract][Full Text] [Related]
13. [Cutaneous malignant melanoma. Excision margins and lymph node dissections]. Sebastian G Hautarzt; 2006 Sep; 57(9):756-63. PubMed ID: 16874532 [TBL] [Abstract][Full Text] [Related]
14. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma. Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Hughes TM; A'Hern RP; Thomas JM Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025 [TBL] [Abstract][Full Text] [Related]
16. [Inguinal recurrence after therapeutic lymphadenectomy in malignant melanoma]. Kretschmer L; Lautenschläger C; Preusser KP; Fiedler H Langenbecks Arch Chir; 1993; 378(4):211-6. PubMed ID: 8366734 [TBL] [Abstract][Full Text] [Related]
17. Regional lymph node dissections in malignant melanoma. Lawton GP; Ariyan S Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563 [TBL] [Abstract][Full Text] [Related]
19. Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Baas PC; Schraffordt Koops H; Hoekstra HJ; van Bruggen JJ; van der Weele LT; Oldhoff J Arch Surg; 1992 Mar; 127(3):281-6. PubMed ID: 1550473 [TBL] [Abstract][Full Text] [Related]
20. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]